Financhill
Back

BeiGene Quote, Financials, Valuation and Earnings

BeiGene Price Quote

$144.40
+5.41 (+3.89%)
(Updated: April 24, 2024 at 10:15 AM ET)

BeiGene Key Stats

Sell
27
BeiGene (BGNE) is a Sell

Day range:
$134.68 - $142.22
52-week range:
$126.97 - $266.67
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
5.93
P/B ratio:
4.1%

Volume:
192.8K
Avg. volume:
195.1K
1-year change:
-46.22%
Market cap:
$14.5B
Revenue:
$2.5B
EPS:
$-8.58

How Much Does BeiGene Make?

  • How Much Are BeiGene's Sales Annually?
    BGNE Revenues are $2.5B
  • How Much Profit Does BeiGene's Make A Year?
    BGNE net income is -$881.7M

Is BeiGene Growing As A Company?

  • What Is BeiGene's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.67%
  • What Is BeiGene's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

BeiGene Stock Price Performance

  • Did BeiGene Stock Go Up Last Month?
    BeiGene share price went down by -8.57% last month
  • Did BGNE's Share Price Rise Over The Last Year?
    BGNE share price fell by -46.22% over the past 1 year

What Is BeiGene 52-Week High & Low?

  • What Is BeiGene’s 52-Week High Share Price?
    BeiGene has traded as high as $266.67 over the past 52 weeks
  • What Is BeiGene’s 52-Week Low Share Price?
    BeiGene has traded as low as $126.97 over the past 52 weeks

BeiGene Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy BeiGene?

  • How Much Debt Does BeiGene Have?
    Total long term debt quarterly is $886M
  • How Much Cash Does BeiGene Have?
    Cash and short term investments quarterly total is $3.2B
  • What Is BeiGene’s Book Value Per Share?
    Book value per share is 33.82

Is BeiGene Cash Flow Positive?

  • What Is BGNE Cash Flow From Operations?
    Cash flow from operations (TTM) is -$1.2B
  • What Is BeiGene’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $416.5M
  • What Is BeiGene’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $60M

BeiGene Return On Invested Capital

  • Is Management Doing A Good Job?
    BGNE return on invested capital is -19.41%
  • What Is BeiGene Return On Assets?
    ROA measures how assets are converting to revenues and is -15%
  • What Is BGNE Return On Equity?
    ROE is a measure of profitability and is -22.45%

BeiGene Earnings Date & Stock Price

  • What Is BeiGene's Stock Price Today?
    A single share of BGNE can be purchased today for 138.99
  • What Is BeiGene’s Stock Symbol?
    BeiGene trades on the nasdaq under the ticker symbol: BGNE
  • When Is BeiGene’s Next Earnings Date?
    The next quarterly earnings date for BeiGene is scheduled on May 3, 2024
  • When Is BGNE's next ex-dividend date?
    BeiGene's next ex-dividend date is April 24, 2024
  • How To Buy BeiGene Stock?
    You can buy BeiGene shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

BeiGene Competitors

  • Who Are BeiGene's Competitors?
    Below is a list of companies who compete with BeiGene or are related in some way:
    • ASLAN Pharmaceuticals Ltd (ASLN)
    • Legend Biotech Corp (LEGN)
    • LumiraDx Ltd (LMDXF)
    • Theravance Biopharma Inc (TBPH)
    • Zai Lab Ltd (ZLAB)

BeiGene Dividend Yield

Data Unavailable

BeiGene Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -0.76%
Revenue: 66.91% -0.61%

Analyst Recommendations

Buy Recommendations: 14
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 268.64
Upside from Last Price: 93.28%

Major Shareholders

  • How many BGNE shares are owned by institutional investors?
    64M BGNE shares are owned by institutional investors
  • How many BGNE shares are owned by insiders?
    9.2M BGNE shares are owned by insiders